E. Dühmke

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

Andreas Engert, Petra Schiller, Andreas Josting et al. · Journal of Clinical Oncology · 2003 · 461 citations

Medicine, Oncology, Radiation Oncology +14

Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial

Andreas Engert, Jeremy Franklin, Hans Theodor Eich et al. · Journal of Clinical Oncology · 2007 · 261 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Primary gastric B-Cell lymphoma: Results of a prospective multicenter study

Wolfgang Fischbach, B Dragosics, Maria–Elisabeth Kolve–Goebeler et al. · Gastroenterology · 2000 · 225 citations · Full text

Medicine, Hematology, Oncology +12

Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group

Andreas Engert, Veronika Ballová, Heinz Haverkamp et al. · Journal of Clinical Oncology · 2005 · 193 citations

Medicine, Geriatric Medicine, Oncology +14

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)

Veronika Ballová, Jens Ulrich Rüffer, Heinz Haverkamp et al. · Annals of Oncology · 2004 · 159 citations

Medicine, Geriatric Medicine, Geriatrics +3